Setting the Standard for NAD+ Restoration in Regulated Markets
CellVive NMN™ (β-Nicotinamide Mononucleotide) is a pharmaceutical-grade longevity ingredient developed by Longevity Life Sciences. CellVive NMN™ is the direct precursor to NAD⁺, which supports energy production, DNA repair, and healthy cellular function. Backed by over 15 peer-reviewed human trials, NMN has been shown to elevate NAD⁺ levels by three to five times within eight weeks. CellVive NMN™ is produced using proprietary enzymatic synthesis to achieve ≥99% purity and manufactured to pharmaceutical grade standards.
CellVive NMN™ has been recommended for inclusion in the Australian Therapeutic Goods Administration Permissible Ingredient Determination.
Expected Gazettal December 2025.
Leading the Global Shift Towards Evidence-based Longevity
_edited.jpg)
What is ?
Australia's Only Regulated & Validated Nicotinamide Mononucleotide (NMN)
Nicotinamide Mononucleotide (NMN) is a molecule naturally found in the body and related to vitamin B₃. It plays a key role as a direct precursor to NAD⁺ (Nicotinamide Adenine Dinucleotide), which is an essential coenzyme involved in energy metabolism and many cellular functions. Science has demonstrated that NAD⁺ levels naturally decline with age, causing age related diseases. NMN has become a focus of scientific research for its role in supporting this vital pathway.
Our Partners
